Mainland China’s regulatory evolution brings greater access to novel drugs
Clarivate
MAY 11, 2023
Hemophagocytic lymphohistiocytosis (HLH) Emapalumab Gamifant Swedish Orphan Biovitrum AB 2022 Patients with refractory or relapsed HLH HLH is an extremely rare, highly progressive hyperinflammatory disorder. There are a lack of available treatment options that address the underlying disease pathology.
52 
Let's personalize your content